Advertisement

Topics

Triumvira Immunologics, Inc. Company Profile

14:11 EDT 24th May 2018 | BioPortfolio

Triumvira Immunologics, Inc. (“Triumvira”) is an immunotherapy company co-founded in 2015 by Dr. Jonathan Bramson at McMaster University and Bloom Burton & Co., with the vision of developing novel T cell therapies that are safer and more efficacious than current gene therapy cancer treatments, including chimeric antigen receptor (CAR) and engineered T cell receptor (TCR) therapies. Our proprietary T cell Antigen Coupler (TAC) technology recruits the entire natural T cell receptor and is independent of the Major Histocompatibility Complex (MHC), allowing for the development of better therapies for a broader range of patients with solid or liquid malignancies and with diseases other than cancer. With operations spanning North America, our corporate offices are located in Austin, Texas, with our research facilities in Hamilton, Ontario. For more information, visit www.triumvira.com or send email inquiries to partners@triumvira.com


News Articles [9 Associated News Articles listed on BioPortfolio]

Triumvira Immunologics to Present at the 25th BioCentury Future Leaders Conference

Triumvira Immunologics, a privately held biopharmaceutical company developing a novel platform for engineering T cells to attack cancers, today announced that it will pres...

Triumvira Immunologics Appoints Cynthia Collins to Board of Directors

Innovative immuno-therapy company welcomes a recognized leader in life sciences and therapeutics Triumvira Immunologics, a privately-held biopharmaceutical company deve...

Triumvira Expands Management Team with Chief Medical Officer and VP of Finance

Innovative immuno-therapy company welcomes proven leaders in pharma and therapeutics Triumvira Immunologics, a privately held biopharmaceutical company developing ...

Triumvira Immunologics to Present at Two Upcoming Conferences: International Society for Cellular Therapy and Bloom Burton & Co. Healthcare Investor Conference

Triumvira Immunologics, Inc., a privately held biopharmaceutical company developing a novel platform for engineering T cells to attack multiple types of cancers, today anno...

Triumvira Immunologics Announces Strategic Relationship for GMP Manufacturing with Centre for Commercialisation of Cancer Immunotherapy

Triumvira Immunologics, a privately held biopharmaceutical company developing a novel platform for engineering T cells to attack multiple cancers, today announced a strateg...

Paul Lammers, M.D., M.Sc. Joins Triumvira as President and Chief Executive Officer

Experienced biotech executive takes helm of promising T-Cell Therapy company as it moves several programs toward clinical testing Triumvira Immunologics Canada Inc. and Triumv...

Triumvira Names a New CEO

Dr. Lammers brings more than 27 years of experience in product and clinical development spanning the pharmaceutical and biotechnology industries.

LaVoieHealthScience Expands Senior Leadership Team, Adds Two New Immuno-Oncology Clients to Roster

Douglas Russell joins LHS as Senior Vice President & General Manager LaVoieHealthScience (LHS), an integrated investor and public relations agency focused on advanc...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [5 Associated Companies listed on BioPortfolio]

Triumvira Immunologics, Inc.

Triumvira Immunologics, Inc. (“Triumvira”) is an immunotherapy company co-founded in 2015 by Dr. Jonathan Bramson at McMaster University and Bloom Burton & Co., with the...

Triumvira Immunologics

Triumvira is developing an engineered T-cell technology called the T-Cell Antigen Coupler (TAC), developed in the laboratory of Dr. Jonathan Bramson at McMaster University in Hami...

Signature Immunologics

Signature Immunologics produces anti-hapten IgGs for High Performance Immunocytochemistry (HPI), targeting key small molecules in cell physiology, including fast neurotransmitter amino acids and pivot...

Quantum Immunologics, Inc.

Signature Immunologics, Inc.

Nil

More Information about "Triumvira Immunologics, Inc." on BioPortfolio

We have published hundreds of Triumvira Immunologics, Inc. news stories on BioPortfolio along with dozens of Triumvira Immunologics, Inc. Clinical Trials and PubMed Articles about Triumvira Immunologics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Triumvira Immunologics, Inc. Companies in our database. You can also find out about relevant Triumvira Immunologics, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record